InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Bishop Hans Edgar, Director. Officer active across 3 companies, notably Lyell Immunopharma, Inc.. In total, 5 reports have been recorded. The latest transaction was filed on 5 April 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
02,880 shares0
Common Stock
SEC:0001562180-22-003313:0·
€221,5791,785 shares@ €124.13410.0007% mcap100.0% of flow
Common Stock
SEC:0001127602-22-010045:0·
€87,688993,428 shares@ €0.08830.013% mcap100.0% of flow
Common Stock
SEC:0001209191-22-013118:0·
546,806 shares
Common Stock
SEC:0001209191-21-042796·
546,806 shares
Common Stock
SEC:0001209191-21-042796:0·
5 of 5 declarations
About Bishop Hans Edgar
Hans Edgar Bishop is a Director at Lyell Immunopharma, Inc., Agilent Technologies, Inc., and Sana Biotechnology, Inc. He contributes to the governance of the companies by participating in strategic decisions. His experience is valuable in guiding these firms towards their objectives.
